Ann Dermatol.  2014 Feb;26(1):134-137. 10.5021/ad.2014.26.1.134.

The Expression of Involucrin, Loricrin, and Filaggrin in Cultured Sebocytes

Affiliations
  • 1Department of Dermatology, Kyungpook National University School of Medicine, Daegu, Korea. weonju@knu.ac.kr

Abstract

No abstract available.


Figure

  • Fig. 1 The expression of involucrin (A), loricrin (B), and filaggrin (C) was very weak in the cytoplasm of cultured sebocytes in immunocytofluorescence. (D) Control (A~D: ×200).

  • Fig. 2 Gene expression of involucrin (A), loricrin (B), and filaggrin (C) in cultured sebocytes after treatment with calcium and VitD (vitamin D), respectively. Cont: control.


Reference

1. Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem. 1995; 270:17702–17711.
Article
2. Zouboulis CC, Adjaye J, Akamatsu H, Moe-Behrens G, Niemann C. Human skin stem cells and the ageing process. Exp Gerontol. 2008; 43:986–997.
Article
3. Schneider MR, Paus R. Sebocytes, multifaceted epithelial cells: lipid production and holocrine secretion. Int J Biochem Cell Biol. 2010; 42:181–185.
Article
4. Zouboulis CC, Xia LQ, Detmar M, Bogdanoff B, Giannakopoulos G, Gollnick H, et al. Culture of human sebocytes and markers of sebocytic differentiation in vitro. Skin Pharmacol. 1991; 4:74–83.
Article
5. Doran TI, Baff R, Jacobs P, Pacia E. Characterization of human sebaceous cells in vitro. J Invest Dermatol. 1991; 96:341–348.
Article
6. Lo Celso C, Berta MA, Braun KM, Frye M, Lyle S, Zouboulis CC, et al. Characterization of bipotential epidermal progenitors derived from human sebaceous gland: contrasting roles of c-Myc and beta-catenin. Stem Cells. 2008; 26:1241–1252.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr